postmarketingu
Postmarketing, commonly referred to as postmarketing surveillance or pharmacovigilance, is the monitoring of the safety and real-world performance of a pharmaceutical product after it has been approved and released to the market. Its aim is to detect adverse drug reactions, medication errors, and other risks that may not have been identified in preapproval trials, and to maintain a favorable benefit–risk balance throughout a product’s lifecycle.
Key activities in postmarketing surveillance include spontaneous adverse event reporting, routine literature monitoring, and active surveillance
Regulatory frameworks vary by country but share core goals: to continuously assess safety after market entry
The field supports ongoing vigilance of medicines in diverse populations and real-world settings but faces challenges